BiotechTube
Interbiome

Interbiome

Boston, United States· Est.
interbiome.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3M

Overview

Interbiome is a private, pre-revenue Contract Manufacturing Organization (CMO) established in 2019 to serve the emerging microbiome therapeutics sector. The company leverages its leadership's deep experience in life sciences and regulatory systems to offer specialized manufacturing services aimed at advancing client programs through clinical development. While initially presented as a developer of therapeutics, its current operational model is squarely focused on providing critical infrastructure and manufacturing services to other drug developers in the microbiome space, positioning itself as an enabler rather than a direct therapeutic competitor.

Gastrointestinal disordersMetabolic disorders

Technology Platform

Specialized contract manufacturing and process development platform for live biotherapeutic products (LBPs) and microbiome-based therapeutics, focusing on GMP-compliant cultivation, formulation, and analytics.

Funding History

1
Total raised:$3M
Seed$3M

Opportunities

The rapidly growing microbiome therapeutics market creates high demand for specialized manufacturing services, a key bottleneck for developers.
As a focused CMO, Interbiome can capture value from multiple client programs without direct therapeutic risk, and potential first approvals in the field would significantly boost sector investment and outsourcing needs.

Risk Factors

Revenue is entirely dependent on the clinical success of client programs, creating high pipeline concentration risk.
The company faces competition from both large, established CMOs and other niche players, and must maintain flawless cGMP compliance to avoid reputational damage in a highly regulated environment.

Competitive Landscape

Interbiome competes in the microbiome-focused CMO space against larger, diversified CDMOs (Contract Development and Manufacturing Organizations) like Lonza, Catalent, and Thermo Fisher Scientific, which are building microbiome capabilities, as well as against other specialized startups. Its differentiation hinges on deep, focused expertise in microbiome-specific manufacturing challenges and a lean, client-centric approach.

More companies in United States →